PMA device
Adiana Contraception System
Hologic, Inc. · Laparoscopic Contraceptive Tubal Occlusion Device (KNH, Class III) · First FDA decision Mar 20, 2012, newest Mar 20, 2012Contraception
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
2
Naming "Adiana Contraception"
MAUDE reports
0
Brand "Adiana Contraception", since 2015
PubMed studies
0
Mentioning "Adiana Contraception"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Adiana Contraception System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- ADIANA CONTRACEPTION SYSTEMPMA supplement
P070022-S025 · Decided Mar 20, 2012 · 69 days after receipt · Normal 180 Day Track
Device type: Laparoscopic contraceptive tubal occlusion device (KNH) · Obstetrics & Gynecology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Adiana Contraception", any status and sponsor, newest update first.
Hologic, Inc.Public (HOLX)
NCT00737061 · 770 participants · Start Nov 2002 · Primary completion Dec 2005
Device: Adiana Transcervical Sterilization System · For: Reproductive Sterilization
Sites: Phoenix, Arizona; Roseville, California; San Rafael, California · 16 sites in all
BayerNot on our public-company list
NCT02532361 · 10,578 participants · Start Aug 2015 · Primary completion Dec 2015
Device: Hysteroscopic device placement including Essure (ESS305, BAY1454032) · For: Hysterectomy
Sites: New Jersey, New Jersey
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Adiana Contraception", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code KNH
524 reports: 66 malfunction, 448 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Adiana Contraception"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code KNH.
- Filshie Clip (Mark VI) SystemFemcare , Ltd. · PMA 2024
- Adiana Permanent Contraception SystemHologic, Inc. · PMA 2012
- Falope-Ring Band Contraceptive Tubal Occlusion SystemGyrus Acmi, Inc. · PMA 2016
- Falope Ring Band and Applicator SystemsGyrus Acmi, Inc. · PMA 2017
- Acmi Falope Ring BandGyrus Acmi, Inc. · PMA 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.